The Current Ratio as of November 2024 (TTM) for Annovis Bio, Inc. (ANVS) is 2.34K

According to Annovis Bio, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 2.34K. This represents a change of 299.11% compared to the average of 587.27 of the last 4 quarters.

Annovis Bio, Inc. (ANVS) Historical Current Ratio (quarterly & annually)

How has ANVS Current Ratio performed in the past?

The mean historical Current Ratio of Annovis Bio, Inc. over the last ten years is 7.55. The current 2.34K Current Ratio has changed 3.11% with respect to the historical average. Over the past ten years (40 quarters), ANVS's Current Ratio was at its highest in in the September 2024 quarter at 2.34K. The Current Ratio was at its lowest in in the March 2018 quarter at 0.

Annovis Bio, Inc. (ANVS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Annovis Bio, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Annovis Bio, Inc. (ANVS) Average Current Ratio

How has ANVS Current Ratio performed in the past?

The current Current Ratio of Annovis Bio, Inc. (ANVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Annovis Bio, Inc. (ANVS) Current Ratio vs. Peers

How is ANVS’s Current Ratio compared to its peers?

Annovis Bio, Inc.’s Current Ratio is greater than Cassava Sciences, Inc. (3.55), greater than Axsome Therapeutics, Inc. (2.44), greater than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than Seres Therapeutics, Inc. (1.12), greater than Anavex Life Sciences Corp. (12.04), greater than Iovance Biotherapeutics, Inc. (4.22), greater than Novavax, Inc. (0.93), greater than Anixa Biosciences, Inc. (11.31), greater than TFF Pharmaceuticals, Inc. (0.89), greater than Immunome, Inc. (6.17), greater than IN8bio, Inc. (1.84), greater than Acumen Pharmaceuticals, Inc. (10.43), greater than Inozyme Pharma, Inc. (7.68), greater than Terns Pharmaceuticals, Inc. (32.99), greater than Day One Biopharmaceuticals, Inc. (14.62), greater than Galera Therapeutics, Inc. (5.63), greater than Cue Biopharma, Inc. (2.22), greater than Lantern Pharma Inc. (8.31), greater than Gracell Biotechnologies Inc. (7.73),

Build a custom stock screener for Annovis Bio, Inc. (ANVS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Annovis Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Annovis Bio, Inc. (ANVS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Annovis Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.